(Q38868069)

7 September 2017

title

Effects of PEGylated paclitaxel nanocrystals on breast cancer and its lung metastasis (English)

1 reference

7 September 2017

1 reference

1

Hua Zhang

1 reference

7 September 2017

Hongxiang Hu

2

1 reference

7 September 2017

Haoran Zhang

3

1 reference

7 September 2017

Wenbing Dai

4

1 reference

7 September 2017

Xinglin Wang

5

1 reference

7 September 2017

Xueqing Wang

6

1 reference

7 September 2017

Qiang Zhang

7

1 reference

7 September 2017

language of work or name

English

0 references

publication date

1 June 2015

1 reference

7 September 2017

1 reference

7 September 2017

volume

7

1 reference

7 September 2017

issue

24

1 reference

7 September 2017

page(s)

10790-10800

1 reference

Paclitaxel and its formulations

7 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1039%2FC4NR07450E

PEG-farnesylthiosalicylate conjugate as a nanomicellar carrier for delivery of paclitaxel

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4NR07450E

Self-assembled chitosan-ceramide nanoparticle for enhanced oral delivery of paclitaxel

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4NR07450E

Modular design of redox-responsive stabilizers for nanocrystals.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4NR07450E

Understanding the structure and stability of paclitaxel nanocrystals

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4NR07450E

Enhanced anticancer activity of nanopreparation containing an MMP2-sensitive PEG-drug conjugate and cell-penetrating moiety

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4NR07450E

Multifunctional drug delivery system for targeting tumor and its acidic microenvironment

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4NR07450E

Paclitaxel loaded PEGylated gleceryl monooleate based nanoparticulate carriers in chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4NR07450E

Nanoparticle albumin-bound paclitaxel: a novel Cremphor-EL-free formulation of paclitaxel

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4NR07450E

Drug nanocrystals in the commercial pharmaceutical development process

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4NR07450E

Paclitaxel nanosuspensions for targeted chemotherapy - nanosuspension preparation, characterization, and use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4NR07450E

Preparation, physical characterization and pharmacokinetic study of paclitaxel nanocrystals

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4NR07450E

Physical and chemical stability of drug nanoparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4NR07450E

PEG - a versatile conjugating ligand for drugs and drug delivery systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4NR07450E

Pegylated liposomal doxorubicin: optimizing the dosing schedule in ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4NR07450E

Multifunctional PEGylated nanoclusters for biomedical applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4NR07450E

Relationship between complement activation, cellular uptake and surface physicochemical aspects of novel PEG-modified nanocapsules.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4NR07450E

Effects of mixed polyethyleneglycol modification on fixed aqueous layer thickness and antitumor activity of doxorubicin containing liposome

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4NR07450E

Nanoscale drug delivery systems for enhanced drug penetration into solid tumors: current progress and opportunities

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4NR07450E

Novel cathepsin B-sensitive paclitaxel conjugate: Higher water solubility, better efficacy and lower toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4NR07450E

Preparation and antitumor study of camptothecin nanocrystals

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4NR07450E

Pharmacokinetics and treatment efficacy of camptothecin nanocrystals on lung metastasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4NR07450E

Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4NR07450E

Nanoparticle PEGylation for imaging and therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4NR07450E

Targeted paclitaxel delivery to tumors using cleavable PEG-conjugated solid lipid nanoparticles.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4NR07450E

Development and evaluation of transferrin-stabilized paclitaxel nanocrystal formulation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4NR07450E

A screening study of surface stabilization during the production of drug nanocrystals

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4NR07450E

21 January 2018

Identifiers

DOI

10.1039/C4NR07450E

1 reference

7 September 2017

1 reference